Clinical Trial Results TV

Main Menu

Series

Duke Clinical Medicine
SCAI TV

Categories


	Search results: 2224 submissions (showing 871 to 885)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44 | Page 45 | Page 46 | Page 47 | Page 48 | Page 49 | Page 50 | Page 51 | Page 52 | Page 53 | Page 54 | Page 55 | Page 56 | Page 57 | Page 58 | Page 59 | Page 60 | Page 61 | Page 62 | Page 63 | Page 64 | Page 65 | Page 66 | Page 67 | Page 68 | Page 69 | Page 70 | Page 71 | Page 72 | Page 73 | Page 74 | Page 75 | Page 76 | Page 77 | Page 78 | Page 79 | Page 80 | Page 81 | Page 82 | Page 83 | Page 84 | Page 85 | Page 86 | Page 87 | Page 88 | Page 89 | Page 90 | Page 91 | Page 92 | Page 93 | Page 94 | Page 95 | Page 96 | Page 97 | Page 98 | Page 99 | Page 100 | Page 101 | Page 102 | Page 103 | Page 104 | Page 105 | Page 106 | Page 107 | Page 108 | Page 109 | Page 110 | Page 111 | Page 112 | Page 113 | Page 114 | Page 115 | Page 116 | Page 117 | Page 118 | Page 119 | Page 120 | Page 121 | Page 122 | Page 123 | Page 124 | Page 125 | Page 126 | Page 127 | Page 128 | Page 129 | Page 130 | Page 131 | Page 132 | Page 133 | Page 134 | Page 135 | Page 136 | Page 137 | Page 138 | Page 139 | Page 140 | Page 141 | Page 142 | Page 143 | Page 144 | Page 145 | Page 146 | Page 147 | Page 148 | Page 149 |

Dr. Uwe Zeymer and Dr. C. Michael Gibson discuss: PRESERVATION I: bioabsorbable cardiac matrix for the prevention of rem
Dr. C. Michael Gibson

Dr. Pamela Douglas and Dr. C. Michael Gibson discuss: Outcomes of an FFRCT diagnostic strategy versus usual care in susp
Dr. C. Michael Gibson

Dr. Marco Valgimigli and Dr. C. Michael Gibson discuss: Minimizing Adverse haemorrhagic events by TRansradial access sit
Dr. C. Michael Gibson

Dr. G�rard Helft and Dr. C. Michael Gibson discuss: The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-elutin
Dr. C. Michael Gibson

Dr. Hisao Ogawa and Dr. C. Michael Gibson discuss: A trial of Telmisartan prevention of cardiovascular diseases (ATTEMPT
Dr. C. Michael Gibson

Dr. Takeshi Kimura and Dr. C. Michael Gibson discuss: ABSORB Japan: 12-month clinical and 13-month angiographic outcomes
Dr. C. Michael Gibson

Dr. Hisao Ogawa presents: ESC 2015 Wrap-Up in Japanese
Dr. C. Michael Gibson

Dr. Thomas MacDonald and Dr. C. Michael Gibson discuss: The Standard care versus Celecoxib Outcome Trial (SCOT); a rando
Dr. C. Michael Gibson

Dr. Gregg Stone and Dr. C. Michael Gibson present: ESC 2015 Wrap-Up
Dr. C. Michael Gibson

Dr. Gregg Stone and Dr. C. Michael Gibson discuss: Peri-infarct zone pacing to prevent adverse left ventricular remodeli
Dr. C. Michael Gibson

Dr. Frank Rademakers and Dr. C. Michael Gibson discuss: Determining Optimal non-invasive Parameters for the Prediction o
Dr. C. Michael Gibson

Dr. Patrick Serruys and Dr. C. Michael Gibson discuss: Everolimus-eluting bioresorbable vascular scaffolds versus durabl
Dr. C. Michael Gibson

Dr. Renato Lopes, Dr. Roberto Giraldez and Dr. Alexandre Quadros present: ESC 2015 Wrap-Up in Portuguese
Dr. C. Michael Gibson

Dr. Renato Lopes and Dr. C. Michael Gibson discuss: Ongoing Randomized Trials of Patients with AFib and ACS
Dr. C. Michael Gibson

Dr. Carlos Morillo and Dr. C. Michael Gibson discuss: The BENznidazole Evaluation For Interrupting Trypanosomiasis trial
Dr. C. Michael Gibson